PRICE T ROWE ASSOCIATES INC /MD/

Position in BBOT — BridgeBio Oncology Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in BBOT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,286,000

-$1,633,106 QoQ

Shares Held

300,000

-31.5% QoQ

Ownership

0.374%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 66 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. BBOT ranks #148 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	SRRK	Scholar Rock Holding Corp	6,794,837	$373,716,035

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,286,000	300,000	-31.5%	Shares	Sole	2026-08-14
2026-03-31	$3,919,106	437,889	-45.5%	Shares	Sole	2026-05-15
2025-12-31	$10,055,237	803,134	-9.3%	Shares	Sole	2026-02-17
2025-09-30	$10,248,786	885,042	—	Shares	Sole	2025-11-14
2025-06-30 HLXB	—	1,071,550	0.0%	Shares	Sole	2025-08-14
2025-03-31 HLXB	—	1,071,550	-1.5%	Shares	Sole	2025-05-14
2024-12-31 HLXB	—	1,087,771	-3.5%	Shares	Sole	2025-02-14
2024-09-30 HLXB	—	1,127,598	-0.3%	Shares	Sole	2024-11-14
2024-06-30 HLXB	—	1,130,677	0.0%	Shares	Sole	2024-08-14
2024-03-31 HLXB	—	1,130,677	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.